1. Home
  2. DCOY vs UGRO Comparison

DCOY vs UGRO Comparison

Compare DCOY & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.07

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$3.15

Market Cap

3.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCOY
UGRO
Founded
N/A
2014
Country
United States
United States
Employees
11
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
3.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
DCOY
UGRO
Price
$6.07
$3.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
13.9K
64.4K
Earning Date
05-16-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$17,399,438.00
Revenue This Year
N/A
$462.72
Revenue Next Year
N/A
$86.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.11
52 Week High
$9.57
$39.68

Technical Indicators

Market Signals
Indicator
DCOY
UGRO
Relative Strength Index (RSI) 47.08 36.47
Support Level $4.98 $2.13
Resistance Level $6.47 $3.41
Average True Range (ATR) 0.88 0.38
MACD -0.16 0.17
Stochastic Oscillator 22.39 25.81

Price Performance

Historical Comparison
DCOY
UGRO

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees' time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: